Brigham and Women's Hospital
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Brigham and Women's Hospital sits in the top decile of US sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count).
Brigham and Women's Hospital: 937 sponsored US clinical trials, 145 recruiting.
Brigham and Women's Hospital sponsors 937 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 608 completed. 124 of these trials are in Phase 3-4 (later-stage) and 197 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Type 2 Diabetes, with 13 trials.
Top-decile sponsor footprint
Brigham and Women's Hospital ranks in the top decile of sponsors by registered trial count (#35 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
608 of 677 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
937 total, page 9 of 19
Replication of the VERO Osteoporosis Trial in Healthcare Claims Data
NCT04879420
ACT for High Frequency Migraine; A Virtual Mindfulness Intervention
NCT05003362
Optimizing Electronic Health Record Prompts With Behavioral Economics to Improve Prescribing for Older Adults
NCT04284553
Replication of the EINSTEIN-PE Anticoagulant Trial in Healthcare Claims Data
NCT04879407
Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data
NCT05086081
Detecting Compartment Syndrome Pain in the Presence of Regional Anesthesia in Healthy Volunteers
NCT04113954
Replication of the INSPIRE Trial in Healthcare Claims Data
NCT05179512
Replication of the AMPLIFY Anticoagulant Trial in Healthcare Claims Data
NCT04736719
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
NCT04736693
Replication of the RECORD1 Anticoagulant Trial in Healthcare Claims Data
NCT05083455
Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data
NCT04736420
Replication of the RECOVER-II Anticoagulant Trial in Healthcare Claims Data
NCT04735523
Replication of the POET-COPD Trial in Healthcare Claims Data
NCT05083429
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
NCT04736433
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
NCT04510220
Phenotyping Mechanistic Pathways for Adverse Health Outcomes in Sleep Apnea
NCT04575740
Calcium Channel Blockade in Primary Aldosteronism
NCT04179019
Replication of the ARISTOTLE Anticoagulant Trial in Healthcare Claims Data
NCT04593030
Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data
NCT04593056
A Pilot Study Examining Diet in Primary Sclerosing Cholangitis
NCT04678219
Sleep and Circadian Treatments for Shift Workers
NCT03813654
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tocilizumab vs Abatacept
NCT04529863
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Tofacitinib vs Abatacept
NCT04529876
Optimizing the Safety of Inter-Hospital Transfer
NCT05876429
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - TNFi vs Abatacept
NCT04529902
Operational Trial of Dayzz App
NCT04224285
Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
NCT04192370
Weight Loss Before Total Joint Arthroplasty Using A Remote Dietitian and Mobile App
NCT04330391
Integrating Chiropractic Care and Mind-Body Training for the Treatment of Nonspecific Chronic Neck Pain
NCT06523036
Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy
NCT04361253
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19
NCT04343898
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications
NCT04535128
Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue
NCT04144257
Acceptability of Telehealth Triage Using Robotic Systems in COVID-19
NCT04452695
COVID-19 Risk Stratification
NCT04339387
A Study of Bedside Versus Hallway Rounding
NCT04754828
Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
NCT04236258
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
NCT03674541
Sleep Bootcamp: A Pilot Tele-Sleep Program for Former National Football League (NFL) Players
NCT04159233
Project 3 Example: Human-AI Collaboration Tester (HAICT) Exp. 7
NCT05272189
ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI
NCT03829475
Replication of the RELY Anticoagulant Trial in Healthcare Claims Data
NCT04593043
Quantitative 3-Dimensional Chest CT Vascular Reconstruction Before and After Anticoagulation for Pulmonary Embolism
NCT04113421
Even-Up to Minimize Secondary Site Pain For Ankle Fracture
NCT04164563
Control:Diabetes Pilot Study I
NCT04158921
Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics
NCT04090190
The Functional Neuroanatomy of the Human Physiological Stress Response
NCT03867344
Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data
NCT04237935
Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data
NCT04237922
Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data
NCT04897958
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 90 |
| Phase 2 | 107 |
| Phase 3 | 47 |
| Phase 4 | 77 |
Therapeutic Areas
What is open in the Brigham and Women's Hospital pipeline
145 recruiting of 937 indexed (15% open); 608 completed (65%).
Phase mix: 124 late (III/IV) vs 197 early (I/II) (early-phase heavy).
Top condition: Type 2 Diabetes (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Brigham and Women's Hospital: open-pipeline peers nationwide
Peers matched on 937 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Brigham and Women's Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 937 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of Minnesota · 966 trials · 19% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Incyte Corporation · 15% recruiting · 239 trials
- Northwestern University · 15% recruiting · 1,209 trials
- Nationwide Children's Hospital · 15% recruiting · 188 trials
- University of Michigan Rogel Cancer Center · 15% recruiting · 292 trials
Related
What to do with this Brigham and Women's Hospital page
937 registered trials is a research-attention snapshot, not an endorsement of Brigham and Women's Hospital or any single study.
- 145 of Brigham and Women's Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 2 Diabetes is the condition Brigham and Women's Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 2 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Brigham and Women's Hospital pipeline card: 937 registered trials from official public datasets.Report a data error.